These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6695620)

  • 1. Cerebral blood flow in Parkinson's syndrome.
    Granérus AK; Nilsson NJ; Suurküla M; Svanborg A
    Adv Neurol; 1984; 40():403-5. PubMed ID: 6695620
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of regional cerebral circulation in parkinsonism patients according the 133Xe clearance findings].
    Man'kovskii NB; Vanishtok AB; Lizogub VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(1):51-5. PubMed ID: 842227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regional cerebral blood flow in the aging human brain and in Alzheimer's dementia and Parkinson's disease].
    Melamed E
    Harefuah; 1982 Nov; 103(10):234-6. PubMed ID: 7182319
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa-induced local cerebral blood flow changes in Parkinson's disease and related disorders.
    Kobari M; Fukuuchi Y; Shinohara T; Obara K; Nogawa S
    J Neurol Sci; 1995 Feb; 128(2):212-8. PubMed ID: 7738597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations made with L-deprenil (Jumex) in the long-term treatment of outpatients with Parkinson's syndrome.
    Gyimóti G; Csanaky A; Leposa D
    Ther Hung; 1983; 31(1):26-30. PubMed ID: 6443750
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperuricemia in Parkinson's syndrome--by chance or probable?].
    Babucke G; Sagebiel L; Mertz DP
    MMW Munch Med Wochenschr; 1976 Nov; 118(46):1489-90. PubMed ID: 825768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Parkinson's syndrome using a new preparation from the series of tricyclic psychotropic drugs].
    Deze J; Völler GW
    Med Welt; 1975 Aug; 26(33-34):1457-62. PubMed ID: 1100988
    [No Abstract]   [Full Text] [Related]  

  • 8. The clinical features of Parkinson's disease in 100 histologically proven cases.
    Hughes AJ; Daniel SE; Lees AJ
    Adv Neurol; 1993; 60():595-9. PubMed ID: 8420197
    [No Abstract]   [Full Text] [Related]  

  • 9. [Crises in the course of Parkinson's disease].
    Danielczyk W
    Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of dopamine on regional cerebral blood flow in patients with Parkinson's disease before and after L-dopa--measurement by Xe-enhanced CT].
    Aiba I; Indo T; Takahashi A
    Rinsho Shinkeigaku; 1994 Nov; 34(11):1099-104. PubMed ID: 7729088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical-pharmacological basis for the clinical use of L-dioxypheny alanine in Parkinson's syndrome].
    Hornykiewicz VO
    Wien Med Wochenschr; 1975 May; 125(21):325-7. PubMed ID: 1216856
    [No Abstract]   [Full Text] [Related]  

  • 12. Progression and prognosis in Parkinson's disease in relation to concomitant cerebral or peripheral vasculopathy.
    Scigliano G; Musicco M; Soliveri P; Girotti F; Giovannini P; Fetoni V; Caraceni T
    Adv Neurol; 1996; 69():305-9. PubMed ID: 8615143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Generating mechanism and treatment of parkinsonian symptoms].
    Narabayashi H
    Rinsho Shinkeigaku; 1982 Dec; 22(12):1055-62. PubMed ID: 7168940
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group.
    Ann Neurol; 1996 Jan; 39(1):37-45. PubMed ID: 8572664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fracture of the distal end of the femur in Parkinson's disease].
    Ferraro C; Lunardo C; Nolli AL
    Clin Ortop; 1974; 25(3):165-73. PubMed ID: 4471321
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinicopharmacological study of long-term Jumex + Dopaflex combination treatment in Parkinson's syndrome.
    Antóny M; Tóth G; Széplaki Z
    Ther Hung; 1982; 30(4):168-71. PubMed ID: 6821398
    [No Abstract]   [Full Text] [Related]  

  • 17. Apomorphine increases blood glucose concentrations in Parkinson's disease.
    Tison F; Fouillet N; Henry P
    Clin Neuropharmacol; 1994 Feb; 17(1):92-5. PubMed ID: 8149364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
    Nygaard TG
    Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebral blood flow (CBF) with 133Xe inhalation method--CBF study during CO2 inhalation (author's transl)].
    Kusunoki T; Masumura M; Tamaki N; Matsumoto S; Yamashita H; Hirayama A; Noda S
    No To Shinkei; 1982 Feb; 34(2):131-7. PubMed ID: 6805490
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebral blood flow and depression].
    Uytdenhoef P; Charles G; Portelange P; Wilmotte J; Mendlewicz J; Jacquy J
    Acta Psychiatr Belg; 1984; 84(2):93-9. PubMed ID: 6741595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.